{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T21:29:09Z","timestamp":1792013349125,"version":"4.4.0"},"reference-count":118,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T00:00:00Z","timestamp":1758499200000},"content-version":"vor","delay-in-days":264,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Journal of Tropical Medicine"],"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Nigeria has the highest burden of hepatitis B virus (HBV) infection in sub\u2010Saharan Africa. However, the lack of a robust surveillance system and program data has limited the understanding of the burden and the distribution of HBV across different populations. This narrative review aimed to summarize available data on the epidemiology of HBV in Nigeria and identify research gaps in the existing literature.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We searched PubMed, Scopus, and Google Scholar for relevant articles published between January 2000 and June 2025. Primary studies, reviews, and reports that contained data of interest, including prevalence, incidence, mode of transmission, mortality, and genotypes, were included in this review. Where available, we restricted our results to findings from representative surveys (conducted across the six geopolitical zones) or systematic reviews. Prevalence rates &lt; 2%, 2%\u20137%, and \u2265 8% were described as low, intermediate, and high, respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Studies on the prevalence of hepatitis B surface antigen (HBsAg) have reported intermediate to high rates in the general population (5.4%\u201313.6%), with evidence suggesting declining trend. The most recent estimates showed a prevalence of 5.4% in 2022, corresponding to approximately 14.4 million people living with HBV. Available data indicate sociodemographic disparities in HBV prevalence, with higher rates among men, adults (&gt; 18\u2009years), and rural dwellers. Reported prevalence rates among specific subpopulations include blood donors (13.2%\u201314.0%), pregnant women (5.5%\u201314.1%), prison inmates (4%\u201342.2%), people who inject drugs (7%\u20137.8%), healthcare workers (1.1%\u201325.7%), female sex workers (0%\u201317.1%), men who have sex with men (8.4%\u201311.7%), and transgender women (15.6%). The prevalence of hepatitis B e\u2010antigen (HBeAg) in the general population ranged from 6.0% to 23.6%. The prevalence of occult HBV infection (OBI) ranged from 0.9% to 17.0%. Genotype E was consistently reported as the predominant HBV genotype. Most studies reported low, intermediate, and high prevalence rates for HBV\u2010hepatitis C virus (HCV), HBV\u2010hepatitis D virus (HDV), and HBV\u2010HIV coinfections, respectively. In 2022, approximately 46,000 deaths were attributed to HBV, translating to a mortality rate of 21 per 100,000 population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>A wide range of HBV prevalence rates has been observed across various population groups in Nigeria. Key research gaps in HBV epidemiology that must be addressed include modes of transmission, incidence rate, prevalence among key populations, prevalence of OBI in the general population, and spatial distribution of the burden.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1155\/jotm\/4939367","type":"journal-article","created":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T12:21:22Z","timestamp":1758543682000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Epidemiology of Hepatitis B Virus Infection in Nigeria: A Narrative Review of Prevalence, Transmission, Genotypes, Coinfections, and Mortality"],"prefix":"10.1155","volume":"2025","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0864-6901","authenticated-orcid":false,"given":"Babayemi O.","family":"Olakunde","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1855-6878","authenticated-orcid":false,"given":"Daniel A.","family":"Adeyinka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olubunmi A.","family":"Olakunde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanley C.","family":"Eneh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Temitayo","family":"Ogundipe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,9,22]]},"reference":[{"key":"e_1_2_13_1_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-023-00760-9"},{"key":"e_1_2_13_2_2","doi-asserted-by":"publisher","DOI":"10.3390\/V14010082"},{"key":"e_1_2_13_3_2","volume-title":"Global Hepatitis Report 2024: Action for Access in low- and middle-income Countries","author":"World Health Orgnaization","year":"2024"},{"key":"e_1_2_13_4_2","volume-title":"Implementing the Global Health Sector Strategies on HIV, Viral Hepatitis and Sexually Transmitted Infections, 2022\u20132030: Report on Progress and Gaps 2024, Second Edition","author":"World Health Organization","year":"2024"},{"key":"e_1_2_13_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(18)30056-6"},{"key":"e_1_2_13_6_2","volume-title":"National Strategic Framework on Viral Hepatitis in Nigeria 2022-2026","author":"Federal Ministry of Health","year":"2022"},{"key":"e_1_2_13_7_2","volume-title":"National Strategic Plan for the Control of Viral Hepatitis in Nigeria (2016-2020)","author":"Federal Ministry of Health","year":"2016"},{"key":"e_1_2_13_8_2","doi-asserted-by":"publisher","DOI":"10.1097\/COH.0000000000000619"},{"key":"e_1_2_13_9_2","volume-title":"Nigeria HIV\/AIDS Indicator and Impact Survey (NAIIS) 2018: Technical Report","author":"Federal Ministry of Health","year":"2019"},{"key":"e_1_2_13_10_2","doi-asserted-by":"publisher","DOI":"10.1093\/epirev\/mxj009"},{"key":"e_1_2_13_11_2","doi-asserted-by":"publisher","DOI":"10.1101\/CSHPERSPECT.A021410"},{"key":"e_1_2_13_12_2","doi-asserted-by":"publisher","DOI":"10.4103\/1119-3077.151035"},{"key":"e_1_2_13_13_2","doi-asserted-by":"publisher","DOI":"10.1186\/S12879-021-06800-6"},{"key":"e_1_2_13_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(22)00124-8"},{"key":"e_1_2_13_15_2","doi-asserted-by":"publisher","DOI":"10.4236\/AID.2023.132016"},{"key":"e_1_2_13_16_2","doi-asserted-by":"publisher","DOI":"10.9734\/BMRJ\/2016\/27331"},{"key":"e_1_2_13_17_2","doi-asserted-by":"publisher","DOI":"10.1371\/JOURNAL.PONE.0248045"},{"key":"e_1_2_13_18_2","doi-asserted-by":"publisher","DOI":"10.26420\/JHEPATRES.2021.1041"},{"key":"e_1_2_13_19_2","doi-asserted-by":"publisher","DOI":"10.62050\/LJSIR2024.V2N1.301"},{"key":"e_1_2_13_20_2","doi-asserted-by":"publisher","DOI":"10.59708\/ajlhts.v2i4.2340"},{"key":"e_1_2_13_21_2","doi-asserted-by":"publisher","DOI":"10.3855\/JIDC.472"},{"key":"e_1_2_13_22_2","doi-asserted-by":"publisher","DOI":"10.23880\/EIJ-16000140"},{"key":"e_1_2_13_23_2","article-title":"Detection of Hepatitis B Virus from Inmates in Correctional Facilities in Niger State","volume":"1","author":"Ojodu A. B.","year":"2023","journal-title":"Covenant Journal Health Life Science"},{"key":"e_1_2_13_24_2","doi-asserted-by":"publisher","DOI":"10.9734\/JAMPS\/2017\/32199"},{"key":"e_1_2_13_25_2","volume-title":"Prevalence and Correlates of HIV, Syphilis, Hepatitis B, Hepatitis C Infections and Sexual Behaviours of Men Who Have Sex with Men in Two Cities in Nigeria","author":"Adebajo S.","year":"2014"},{"key":"e_1_2_13_26_2","doi-asserted-by":"publisher","DOI":"10.1186\/S12879-021-06368-1"},{"key":"e_1_2_13_27_2","doi-asserted-by":"publisher","DOI":"10.9734\/ISRR\/2017\/34506"},{"key":"e_1_2_13_28_2","doi-asserted-by":"publisher","DOI":"10.3390\/VENEREOLOGY1010009"},{"key":"e_1_2_13_29_2","doi-asserted-by":"publisher","DOI":"10.1590\/S0036-46652008000400006"},{"key":"e_1_2_13_30_2","first-page":"77","article-title":"Hepatitis B Surface Antigenaemia Among High Risk Groups in Northeastern Nigeria","volume":"69","author":"Bukbuk D.","year":"2016","journal-title":"Nigerian Medical Practitioner"},{"key":"e_1_2_13_31_2","doi-asserted-by":"publisher","DOI":"10.1186\/S12889-024-18675-8"},{"key":"e_1_2_13_32_2","doi-asserted-by":"publisher","DOI":"10.1177\/0956462413477553"},{"key":"e_1_2_13_33_2","doi-asserted-by":"publisher","DOI":"10.11604\/PAMJ.2016.23.160.8710"},{"key":"e_1_2_13_34_2","doi-asserted-by":"publisher","DOI":"10.7860\/JCDR\/2016\/15936.7329"},{"key":"e_1_2_13_35_2","first-page":"287","article-title":"Seroprevalence of Hepatitis B Surface Antigenemia Among Health Care Workers in A Nigerian Tertiary Health Institution","volume":"10","author":"Ajayi A. O.","year":"2007","journal-title":"Nigerian Journal of Clinical Practice"},{"key":"e_1_2_13_36_2","doi-asserted-by":"publisher","DOI":"10.9790\/1959-1002050913"},{"key":"e_1_2_13_37_2","doi-asserted-by":"publisher","DOI":"10.1177\/2010105820923681"},{"key":"e_1_2_13_38_2","first-page":"373","article-title":"Hepatitis B and C Virus Among Health Care Workers in National Institute for Pharmaceutical Research and Development (NIPRD)","volume":"05","author":"Ya\u2019aba Y.","year":"2019","journal-title":"Iranian Journal of Health, Safety and Environment"},{"key":"e_1_2_13_39_2","doi-asserted-by":"publisher","DOI":"10.3396\/ijic.v12i2.013.16"},{"key":"e_1_2_13_40_2","doi-asserted-by":"publisher","DOI":"10.4103\/NJCP.NJCP_671_19"},{"key":"e_1_2_13_41_2","doi-asserted-by":"publisher","DOI":"10.4103\/AAM.AAM_44_21"},{"key":"e_1_2_13_42_2","doi-asserted-by":"publisher","DOI":"10.21203\/RS.3.RS-3069564\/V1"},{"key":"e_1_2_13_43_2","doi-asserted-by":"publisher","DOI":"10.4314\/EAMJ.V77I5.46634"},{"key":"e_1_2_13_44_2","doi-asserted-by":"crossref","unstructured":"SaniN. BitrusI. SarkiA. andMujahidN. S. Seroprevalence of Hepatitis B and C Among Healthcare Workers in Dutse Metropolis Jigawa State Nigeria 2017.","DOI":"10.1101\/327940"},{"key":"e_1_2_13_45_2","doi-asserted-by":"publisher","DOI":"10.4172\/2155-6113.1000308"},{"key":"e_1_2_13_46_2","doi-asserted-by":"publisher","DOI":"10.1371\/JOURNAL.PONE.0259218"},{"key":"e_1_2_13_47_2","doi-asserted-by":"publisher","DOI":"10.1177\/0049475514560211"},{"key":"e_1_2_13_48_2","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.15-0874"},{"key":"e_1_2_13_49_2","doi-asserted-by":"publisher","DOI":"10.4103\/NJM.NJM_24_23"},{"key":"e_1_2_13_50_2","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/2622291"},{"key":"e_1_2_13_51_2","doi-asserted-by":"publisher","DOI":"10.1016\/J.EJCA.2010.03.034"},{"key":"e_1_2_13_52_2","doi-asserted-by":"publisher","DOI":"10.4103\/GHEP.GHEP_34_22"},{"key":"e_1_2_13_53_2","doi-asserted-by":"publisher","DOI":"10.1016\/J.SCIAF.2023.E01702"},{"key":"e_1_2_13_54_2","doi-asserted-by":"publisher","DOI":"10.1371\/JOURNAL.PONE.0131912"},{"key":"e_1_2_13_55_2","doi-asserted-by":"publisher","DOI":"10.1179\/2047773214Y.0000000144"},{"key":"e_1_2_13_56_2","first-page":"87","article-title":"Occult HBV Infection in Nigeria","volume":"6","author":"Akintule O. A.","year":"2018","journal-title":"Arch basic Appl Med"},{"key":"e_1_2_13_57_2","doi-asserted-by":"publisher","DOI":"10.1186\/S12985-016-0533-3"},{"key":"e_1_2_13_58_2","doi-asserted-by":"publisher","DOI":"10.4103\/NMJ.NMJ_29_19"},{"key":"e_1_2_13_59_2","doi-asserted-by":"publisher","DOI":"10.4314\/AHS.V21I3.22"},{"key":"e_1_2_13_60_2","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/796121"},{"key":"e_1_2_13_61_2","doi-asserted-by":"publisher","DOI":"10.4103\/NJCP.NJCP_273_17"},{"key":"e_1_2_13_62_2","doi-asserted-by":"publisher","DOI":"10.3329\/JHPN.V30I4.13289"},{"key":"e_1_2_13_63_2","doi-asserted-by":"publisher","DOI":"10.23937\/2474-3658\/1510115"},{"key":"e_1_2_13_64_2","doi-asserted-by":"publisher","DOI":"10.1002\/JMV.23418"},{"key":"e_1_2_13_65_2","doi-asserted-by":"publisher","DOI":"10.31579\/2768-0487\/020"},{"key":"e_1_2_13_66_2","doi-asserted-by":"publisher","DOI":"10.3855\/jidc.2747"},{"key":"e_1_2_13_67_2","doi-asserted-by":"publisher","DOI":"10.5580\/A7913"},{"key":"e_1_2_13_68_2","article-title":"Comparing Serological Markers of Hepatitis B Virus Infection Among People Living with HIV\/AIDS and HIV Seronegative Individuals","volume":"2","author":"Ijarotimi O.","year":"2015","journal-title":"Journal of Hepatitis Research"},{"key":"e_1_2_13_69_2","doi-asserted-by":"publisher","DOI":"10.1080\/21505594.2023.2218076"},{"key":"e_1_2_13_70_2","doi-asserted-by":"publisher","DOI":"10.4103\/NPMJ.NPMJ_59_19"},{"key":"e_1_2_13_71_2","doi-asserted-by":"publisher","DOI":"10.1371\/JOURNAL.PONE.0011615"},{"key":"e_1_2_13_72_2","doi-asserted-by":"publisher","DOI":"10.1111\/J.1469-0691.2010.03205.X"},{"key":"e_1_2_13_73_2","doi-asserted-by":"publisher","DOI":"10.3390\/V13071273"},{"key":"e_1_2_13_74_2","doi-asserted-by":"publisher","DOI":"10.3390\/v15112188"},{"key":"e_1_2_13_75_2","doi-asserted-by":"publisher","DOI":"10.4314\/AHS.V22I1.60"},{"key":"e_1_2_13_76_2","doi-asserted-by":"publisher","DOI":"10.1016\/J.SCIAF.2019.E00122"},{"key":"e_1_2_13_77_2","doi-asserted-by":"publisher","DOI":"10.1186\/S12985-021-01493-4"},{"key":"e_1_2_13_78_2","doi-asserted-by":"publisher","DOI":"10.1177\/13596535251333259"},{"key":"e_1_2_13_79_2","doi-asserted-by":"publisher","DOI":"10.7196\/SAMJ.2017.v107i4.12198"},{"key":"e_1_2_13_80_2","doi-asserted-by":"publisher","DOI":"10.11648\/J.EJPM.S.2017050101.12"},{"key":"e_1_2_13_81_2","doi-asserted-by":"publisher","DOI":"10.1016\/J.SCIAF.2021.E00985"},{"key":"e_1_2_13_82_2","doi-asserted-by":"publisher","DOI":"10.4103\/2141-9248.144925"},{"key":"e_1_2_13_83_2","doi-asserted-by":"publisher","DOI":"10.11604\/pamj.2014.17.197.2310"},{"key":"e_1_2_13_84_2","doi-asserted-by":"publisher","DOI":"10.4314\/JCM.V23I1.1"},{"key":"e_1_2_13_85_2","doi-asserted-by":"publisher","DOI":"10.1080\/15321819.2014.899256"},{"key":"e_1_2_13_86_2","doi-asserted-by":"publisher","DOI":"10.11604\/PAMJ.2023.46.82.40530"},{"key":"e_1_2_13_87_2","first-page":"274","article-title":"Prevalence of Hepatitis B and C Virus Infection Among People of a Local Community in Keffi, Nigeria","volume":"4","author":"Pennap G.","year":"2010","journal-title":"African Journal of Microbiology Research"},{"key":"e_1_2_13_88_2","doi-asserted-by":"publisher","DOI":"10.11648\/J.AJBLS.20150303.15"},{"key":"e_1_2_13_89_2","doi-asserted-by":"publisher","DOI":"10.3390\/v16111723"},{"key":"e_1_2_13_90_2","doi-asserted-by":"publisher","DOI":"10.3390\/V16081236"},{"key":"e_1_2_13_91_2","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens14010101"},{"key":"e_1_2_13_92_2","doi-asserted-by":"publisher","DOI":"10.1080\/01443610120085528"},{"key":"e_1_2_13_93_2","doi-asserted-by":"publisher","DOI":"10.1093\/tropej\/fmv035"},{"key":"e_1_2_13_94_2","doi-asserted-by":"publisher","DOI":"10.1080\/01443610600963986"},{"key":"e_1_2_13_95_2","doi-asserted-by":"publisher","DOI":"10.3109\/00016349.2010.482580"},{"key":"e_1_2_13_96_2","doi-asserted-by":"publisher","DOI":"10.4314\/njp.v42i3.5"},{"key":"e_1_2_13_97_2","doi-asserted-by":"publisher","DOI":"10.1177\/1178122X18792859"},{"key":"e_1_2_13_98_2","doi-asserted-by":"publisher","DOI":"10.1016\/J.SCIAF.2019.E00121"},{"key":"e_1_2_13_99_2","volume-title":"Demographic Statistical Bulletin 2022","author":"National Bureau of Statistics","year":"2023"},{"key":"e_1_2_13_100_2","doi-asserted-by":"publisher","DOI":"10.3390\/TROPICALMED8100474"},{"key":"e_1_2_13_101_2","unstructured":"World Health Organization Hepatitis B Vaccination Coverage 2024 https:\/\/immunizationdata.who.int\/global\/wiise-detail-page\/hepatitis-b-vaccination-coverage."},{"key":"e_1_2_13_102_2","doi-asserted-by":"publisher","DOI":"10.1093\/TRSTMH\/TRAB054"},{"key":"e_1_2_13_103_2","doi-asserted-by":"publisher","DOI":"10.1186\/S12889-018-5432-7"},{"key":"e_1_2_13_104_2","doi-asserted-by":"publisher","DOI":"10.1371\/JOURNAL.PGPH.0000992"},{"key":"e_1_2_13_105_2","doi-asserted-by":"publisher","DOI":"10.1371\/JOURNAL.PONE.0234348"},{"key":"e_1_2_13_106_2","doi-asserted-by":"publisher","DOI":"10.26717\/BJSTR.2024.58.009168"},{"key":"e_1_2_13_107_2","doi-asserted-by":"publisher","DOI":"10.3390\/IJMS232415973"},{"key":"e_1_2_13_108_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.38.suppl_2.s5"},{"key":"e_1_2_13_109_2","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2019.1607132"},{"key":"e_1_2_13_110_2","doi-asserted-by":"publisher","DOI":"10.1038\/S41598-023-32865-1"},{"key":"e_1_2_13_111_2","doi-asserted-by":"publisher","DOI":"10.3748\/WJG.V20.I18.5427"},{"key":"e_1_2_13_112_2","doi-asserted-by":"publisher","DOI":"10.1111\/J.1440-1746.2010.06541.X"},{"key":"e_1_2_13_113_2","doi-asserted-by":"publisher","DOI":"10.1111\/JVH.12018"},{"key":"e_1_2_13_114_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(22)00386-7"},{"key":"e_1_2_13_115_2","unstructured":"World Health Organization Hepatitis-Chronic Hepatitis Treatment Rate as Percentage of Total Infected 2025 https:\/\/www.who.int\/data\/gho\/data\/indicators\/indicator-details\/GHO\/hepatitis---chronic-hepatitis-treatment-rate-as-percentage-of-total-infected."},{"key":"e_1_2_13_116_2","doi-asserted-by":"publisher","DOI":"10.3390\/PATHOGENS14020169"},{"key":"e_1_2_13_117_2","doi-asserted-by":"publisher","DOI":"10.1186\/S44263-023-00026-1"},{"key":"e_1_2_13_118_2","volume-title":"National Guidelines for the Prevention, Care and Treatment of Viral Hepatitis B & C in Nigeria","author":"Federal Minstry of Health","year":"2016"}],"container-title":["Journal of Tropical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1155\/jotm\/4939367","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1155\/jotm\/4939367","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1155\/jotm\/4939367","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T11:55:31Z","timestamp":1777636531000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1155\/jotm\/4939367"}},"subtitle":[],"editor":[{"given":"Priya","family":"Gusain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":118,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["10.1155\/jotm\/4939367"],"URL":"https:\/\/doi.org\/10.1155\/jotm\/4939367","archive":["Portico"],"relation":{},"ISSN":["1687-9686","1687-9694"],"issn-type":[{"value":"1687-9686","type":"print"},{"value":"1687-9694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"2024-12-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-08","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-22","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"4939367"}}